These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 15772011)
1. [Relationship between plasma homocysteine and chronic complications in type 2 diabetes mellitus]. Li WP; Li W; Yang T Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):349-50. PubMed ID: 15772011 [TBL] [Abstract][Full Text] [Related]
2. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus. Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492 [TBL] [Abstract][Full Text] [Related]
3. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels. Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661 [TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy. Goldstein M; Leibovitch I; Yeffimov I; Gavendo S; Sela BA; Loewenstein A Eye (Lond); 2004 May; 18(5):460-5. PubMed ID: 15131674 [TBL] [Abstract][Full Text] [Related]
6. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance. Veldman BA; Vervoort G; Blom H; Smits P Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Signorello MG; Viviani GL; Armani U; Cerone R; Minniti G; Piana A; Leoncini G Thromb Res; 2007; 120(4):607-13. PubMed ID: 17188741 [TBL] [Abstract][Full Text] [Related]
8. [Clinical relevance of homocysteine monitoring in the diabetic patient]. Benmerabet S; Fredenrich A; Robillon JF; Canivet B; Candito M; Van Obberghen E Diabetes Metab; 2002 Dec; 28(6 Pt 1):510-5. PubMed ID: 12522334 [TBL] [Abstract][Full Text] [Related]
9. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117 [TBL] [Abstract][Full Text] [Related]
10. Elevated level of plasma homocysteine in patients with slow coronary flow. Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886 [TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers. Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study. Spoelstra-De Man AM; Smulders YM; Dekker JM; Heine RJ; Bouter LM; Nijpels G; Stehouwer CD J Intern Med; 2005 Dec; 258(6):536-43. PubMed ID: 16313477 [TBL] [Abstract][Full Text] [Related]
13. [Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus]. Zied A; Oudi M; Chahib M; Olfa E; Brahim N; Hédi M; Habib H; Borni Z; Salem M Tunis Med; 2005 Sep; 83(9):537-40. PubMed ID: 16383199 [TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine levels in children and adolescents with type 1 diabetes. Atabek ME; Pirgon O; Karagozoglu E Indian Pediatr; 2006 May; 43(5):401-7. PubMed ID: 16735761 [TBL] [Abstract][Full Text] [Related]
15. [Chronic complication of diabetes and homocysteine]. Idzior-Waluś B; Cieślik G Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598 [TBL] [Abstract][Full Text] [Related]
16. Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients. Anan F; Masaki T; Umeno Y; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H Metabolism; 2007 Oct; 56(10):1390-5. PubMed ID: 17884450 [TBL] [Abstract][Full Text] [Related]
17. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193 [TBL] [Abstract][Full Text] [Related]
18. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes. Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288 [TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinaemia: risk of retinal vascular occlusion. Yaghoubi GH; Madarshahian F; Mosavi M East Mediterr Health J; 2004; 10(4-5):633-9. PubMed ID: 16335656 [TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus and hyperhomocysteinemia. van Guldener C; Stehouwer CD Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]